VISIOMED GROUP EO 0,01VISIOMED GROUP EO 0,01VISIOMED GROUP EO 0,01

VISIOMED GROUP EO 0,01

No trades
See on Supercharts
Market capitalization
‪55.69 M‬EUR
−0.0037EUR
‪−1.10 M‬EUR
‪13.70 M‬EUR
‪152.78 M‬
Beta (1Y)
0.81

About VISIOMED GROUP

CEO
Clement Pacaud
Headquarters
Paris
Founded
2009
ISIN
FR0013481835
FIGI
BBG00LG7BJL3
Visiomed Group SA engages in the development and distribution of healthcare products and services. It operates through the Connected Health, Digitalized Medical Centers, and Other Medical Products and Services segments. The Connected Health segment refers to the strategic activity of the firm which includes telemedicine. The Digitalized Medical Centers segment includes the digitalization of patients' journey that allows taking samples using robotics and connected medical devices and delivering of results using artificial intelligence. The Other Medical Products and Services segment covers historical residual activities of the group and the sales of personal protective and testing equipment. The company was founded by Eric Sebban in June 2007 and is headquartered in Paris, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on MUN exchange VISIOMED GROUP EO 0,01 stocks are traded under the ticker 7V91.
Yes, you can track VISIOMED GROUP EO 0,01 financials in yearly and quarterly reports right on TradingView.
7V91 net income for the last quarter is ‪−425.00 K‬ EUR, while the quarter before that showed ‪−675.00 K‬ EUR of net income which accounts for 37.04% change. Track more VISIOMED GROUP EO 0,01 financial stats to get the full picture.
No, 7V91 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 7V91 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VISIOMED GROUP EO 0,01 stock right from TradingView charts — choose your broker and connect to your account.
7V91 reached its all-time high on Jun 15, 2023 with the price of 0.5345 EUR, and its all-time low was 0.0912 EUR and was reached on Dec 22, 2021. View more price dynamics on 7V91 chart.
See other stocks reaching their highest and lowest prices.
We've gathered analysts' opinions on VISIOMED GROUP EO 0,01 future price: according to them, 7V91 price has a max estimate of 0.70 EUR and a min estimate of 0.70 EUR. Watch 7V91 chart and read a more detailed VISIOMED GROUP EO 0,01 stock forecast: see what analysts think of VISIOMED GROUP EO 0,01 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VISIOMED GROUP EO 0,01 EBITDA is ‪−6.47 M‬ EUR, and current EBITDA margin is −4.38%. See more stats in VISIOMED GROUP EO 0,01 financial statements.